CD57 identifies T cells with functional senescence before terminal differentiation and relative telomere shortening in patients with activated PI3 kinase delta syndrome

Immunol Cell Biol. 2018 Nov;96(10):1060-1071. doi: 10.1111/imcb.12169. Epub 2018 Jun 14.

Abstract

Premature T-cell immunosenescence with CD57+ CD8+ T-cell accumulation has been linked to immunodeficiency and autoimmunity in primary immunodeficiencies including activated PI3 kinase delta syndrome (APDS). To address whether CD57 marks the typical senescent T-cell population seen in adult individuals or identifies a distinct population in APDS, we compared CD57+ CD8+ T cells from mostly pediatric APDS patients to those of healthy adults with similarly prominent senescent T cells. CD57+ CD8+ T cells from APDS patients were less differentiated with more CD27+ CD28+ effector memory T cells showing increased PD1 and Eomesodermin expression. In addition, transition of naïve to CD57+ CD8+ T cells was not associated with the characteristic telomere shortening. Nevertheless, they showed the increased interferon-gamma secretion, enhanced degranulation and reduced in vitro proliferation typical of senescent CD57+ CD8+ T cells. Thus, hyperactive PI3 kinase signaling favors premature accumulation of a CD57+ CD8+ T-cell population, which shows most functional features of typical senescent T cells, but is different in terms of differentiation and relative telomere shortening. Initial observations indicate that this specific differentiation state may offer the opportunity to revert premature T-cell immunosenescence and its potential contribution to inflammation and immunodeficiency in APDS.

Keywords: Activated PI3Kdelta syndrome; CD57; T-cell differentiation; T-cell senescence; immunodeficiency; telomeres.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD57 Antigens / metabolism*
  • Cell Differentiation* / genetics
  • Cell Differentiation* / immunology
  • Cellular Senescence / genetics
  • Cellular Senescence / immunology
  • Class I Phosphatidylinositol 3-Kinases / metabolism
  • Cytokines / metabolism
  • Humans
  • Immunologic Deficiency Syndromes / etiology*
  • Immunologic Deficiency Syndromes / metabolism*
  • Immunophenotyping
  • Lymphocyte Count
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Primary Immunodeficiency Diseases
  • Sirolimus / pharmacology
  • T-Lymphocyte Subsets / drug effects
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocyte Subsets / metabolism*
  • Telomere Shortening*

Substances

  • CD57 Antigens
  • Cytokines
  • Class I Phosphatidylinositol 3-Kinases
  • Sirolimus

Supplementary concepts

  • Activated PI3K-delta Syndrome